NCT03520582

Brief Summary

The aim of this study is to evaluate the technical feasibility of the new tube placement technology in healthy volunteers and, if proven feasible, in critically ill patients requiring placement of a feeding tube.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2016

Completed
11 months until next milestone

Study Start

First participant enrolled

November 6, 2017

Completed
6 months until next milestone

First Posted

Study publicly available on registry

May 11, 2018

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2018

Completed
Last Updated

September 7, 2018

Status Verified

September 1, 2018

Enrollment Period

7 months

First QC Date

December 22, 2016

Last Update Submit

September 5, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Success rate of postpyloric placement, time to reach intragastric and postpyloric position, ease of insertion, handling and image quality.

    using a visual analog scale of 1-10, with 1 indicating the best value

    During Intervention Visit, an average of 24 hours

Secondary Outcomes (13)

  • In healthy volunteers, time required to reach gastric and postpyloric placement

    During Intervention Visit, an average of 24 hours

  • In healthy volunteers, ease of insertion, handling, and image quality assessed

    During Intervention Visit, an average of 24 hours

  • In healthy volunteers, Usability of specific features - tip steerability, lens rinsing and flushing, air insufflation and fluid extraction

    During Intervention Visit, an average of 24 hours

  • In patients: Necessity of use of additional sedation/analgesia for the procedure in addition to already established sedation in the context of mechanical ventilation.

    During Intervention Visit, an average of 24 hours

  • In patients: Ease of insertion, handling, and image quality assessed using a visual analog scale of 1-10, with 1 indicating the best value.

    During Intervention Visit, an average of 24 hours

  • +8 more secondary outcomes

Study Arms (2)

Volunteers

Cohort of 10 healthy subjects. The tube will be placed and removed by a gastroenterologist experienced in performing endoscopic postpyloric tube placement. Secondly, a second tube will be placed and removed.

Device: Tube placement

Mechanically ventilated ICU

Cohort of 20 mechanically ventilated intensive care patients requiring a placement of a postpyloric feeding tube on clinical indications.

Device: Tube placement

Interventions

Placement of enteral feeding tubes

Mechanically ventilated ICUVolunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient in ICU mechanically ventilated and requiring a placement of a postpyloric feeding tube

You may qualify if:

  • Healthy volunteers
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Age \>18 years
  • Patients
  • Age \>18 years
  • mechanically ventilated and requiring a placement of a postpyloric feeding tube on clinical indications
  • Informed Consent as documented by signature of relatives

You may not qualify if:

  • Healthy volunteers and patients
  • Unrepaired tracheoesophageal fistula
  • history of prior esophageal or gastric surgery
  • esophageal obstruction, stricture, varices or diverticulum
  • esophageal or gastric perforation, gastric or esophageal bleeding
  • recent oropharyngeal surgery
  • cervical spine injury or anomaly
  • know severe coagulopathy (defined as thrombocyte count less than 30x10e9/l or International Normalized Ratio (INR) \> 3)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsklinik für Intensivmedizin

Bern, 3010, Switzerland

Location

Study Officials

  • Tobias Merz, Dr. med.

    Inselspital Bern, Universitätsklinik für Intensivmedizin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2016

First Posted

May 11, 2018

Study Start

November 6, 2017

Primary Completion

June 7, 2018

Study Completion

July 30, 2018

Last Updated

September 7, 2018

Record last verified: 2018-09

Locations